No Data
No Data
Psyence Biomedical Transitions CRO for Psilocybin Trial in April 2025
Psyence Biomedical Announces Special Shareholder Meeting for Share Consolidation
Psyence Biomedical Enhances Scientific Advisory Board With New Appointment
Express News | Psyence Biomedical Ltd Files for Mixed Shelf of up to $75Ln - SEC Filing
Press Release: Psyence Biomed Names Albert P. Garcia-Romeu, Ph.D. as Chair of Its Newly Created Scientific Advisory Board
Express News | Psyence Biomed Names Albert P. Garcia-Romeu, Ph.d. as Chair of Its Newly Created Scientific Advisory Board